464 related articles for article (PubMed ID: 23792936)
1. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
[TBL] [Abstract][Full Text] [Related]
2. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
3. Reference intervals for serum concentrations of three bone turnover markers for men and women.
Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
[TBL] [Abstract][Full Text] [Related]
4. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
[TBL] [Abstract][Full Text] [Related]
8. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
[TBL] [Abstract][Full Text] [Related]
9. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
Nelson AE; Howe CJ; Nguyen TV; Leung KC; Trout GJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2006 Nov; 91(11):4424-32. PubMed ID: 16912136
[TBL] [Abstract][Full Text] [Related]
10. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.
Chubb SA; Byrnes E; Manning L; Beilby JP; Ebeling PR; Vasikaran SD; Golledge J; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2015 Jan; 100(1):90-9. PubMed ID: 25322270
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse.
Krusenstjerna-Hafstrøm T; Rasmussen MH; Raschke M; Govender S; Madsen J; Christiansen JS
Growth Horm IGF Res; 2011 Dec; 21(6):331-5. PubMed ID: 21963127
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
13. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
15. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
[TBL] [Abstract][Full Text] [Related]
16. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population.
Hannemann A; Wallaschofski H; Rettig R; Völzke H; Samietz S; Nauck M; Bidlingmaier M; Friedrich N
Horm Metab Res; 2012 Mar; 44(3):228-33. PubMed ID: 22328165
[TBL] [Abstract][Full Text] [Related]
17. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
18. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children.
Bini V; Igli Baroncelli G; Papi F; Celi F; Saggese G; Falorni A
Horm Res; 2004; 61(4):170-5. PubMed ID: 14726619
[TBL] [Abstract][Full Text] [Related]
19. Effect of age-related chronic immobility on markers of bone turnover.
Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
[TBL] [Abstract][Full Text] [Related]
20. Relation of insulin-like growth factor-I and IGF binding protein 3 with markers of inflammation: results of a population-based study.
Lohr J; Grotevendt A; Nauck M; Völzke H; Wallaschofski H; Friedrich N
Clin Endocrinol (Oxf); 2014 Jan; 80(1):148-54. PubMed ID: 23662939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]